Table 1.
Subject characteristics.
| Participant ID | Group | Sex | Age | Height (cm) | Weight (kg) | Surgery-HAL interval (days) |
|---|---|---|---|---|---|---|
| A1 | Acute | F | 78 | 146 | 51 | 15 |
| A2 | Acute | M | 64 | 165 | 90 | 26 |
| A3 | Acute | M | 52 | 180 | 100 | 18 |
| A4 | Acute | F | 63 | 154 | 56 | 32 |
| A5 | Acute | F | 41 | 156 | 79 | 31 |
| A6 | Acute | M | 49 | 169 | 80 | 28 |
| C1 | Chronic | M | 70 | 168 | 71 | 288 |
| C2 | Chronic | M | 75 | 168 | 78 | 287 |
| C3 | Chronic | M | 68 | 174 | 64 | 3655 |
| C4 | Chronic | M | 78 | 159 | 61 | 372 |
| C5 | Chronic | M | 76 | 166 | 63 | 2188 |
| C6 | Chronic | M | 58 | 176 | 72 | 540 |
| C7 | Chronic | M | 66 | 157 | 74 | 730 |
| C8 | Chronic | M | 70 | 163 | 69 | 958 |
| C9 | Chronic | M | 44 | 174 | 100 | 191 |
| H1 | Healthy | F | 56 | 157 | 59 | - |
| H2 | Healthy | F | 42 | 161 | 49 | - |
| H3 | Healthy | F | 59 | 152 | 53 | - |
| H4 | Healthy | F | 67 | 164 | 50 | - |
| H5 | Healthy | F | 60 | 158 | 57 | - |
| H6 | Healthy | M | 50 | 163 | 58 | - |
| H7 | Healthy | M | 45 | 164 | 61 | - |
| H8 | Healthy | M | 77 | 170 | 59 | - |
| H9 | Healthy | M | 66 | 166 | 62 | - |
Surgery-HAL interval refers to the number of days elapsed from the surgery to the beginning of HAL therapy.